Fundraising FoxBhtherapeutics
2 known investors
Find your way into Bhtherapeutics
Sign up to see every warm intro you have to Bhtherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bhtherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them. It develops a pipeline of medicines and conducts clinical trials.
Founders & leadership
JJ
J. Jean Cui, Ph.D.Scientific Founder, President and CEO
YP
Y. Peter Li, Ph.D., MBACofounder and Executive Chairman
Investors · 2
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Bhtherapeutics do?
- BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them. It develops a pipeline of medicines and conducts clinical trials.
- Who founded Bhtherapeutics?
- Bhtherapeutics was founded by J. Jean Cui, Ph.D., Y. Peter Li, Ph.D., MBA.
- Who are Bhtherapeutics's investors?
- Bhtherapeutics's investors include OrbiMed, Vivo Capital.